Skip to main content

Reply to “Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD”

This is a preview of subscription content, access via your institution.

Abbreviations

PPI:

Proton pump inhibitor

OR:

Odds ratio

CI:

Confidence interval

ESD:

Endoscopic submucosal dissection

SLE:

Second-look endoscopy

References

  1. 1.

    Abe H, Hatta W, Ogata Y, et al. Prevention of delayed bleeding with vonoprazan in upper gastrointestinal endoscopic treatment. J Gastroenterol. 2021;56:640–50.

    CAS  Article  Google Scholar 

  2. 2.

    Shiratori Y, Niikura R, Ishii N, et al. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study. Gastrointest Endosc. 2021. https://doi.org/10.1016/j.gie.2021.06.032.

    Article  PubMed  Google Scholar 

  3. 3.

    Hatta W, Tsuji Y, Yoshio T, et al. Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut. 2021;70:476–84.

    CAS  Article  Google Scholar 

  4. 4.

    Hamada K, Uedo N, Tonai Y, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study. J Gastroenterol. 2019;54:122–30.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Waku Hatta.

Ethics declarations

Conflict of interest

Atsushi Masamune declared that he received lecture honoraria from Takeda Pharmaceutical Co., Ltd., Daiichi Sankyo, Inc., and Mylan N.V. and he received commercial research funding from Otsuka Pharmaceutical Co., Ltd., EA Pharma Co., Ltd., Asahi Kasei Pharma Corp., Eisai Co., Ltd., AbbVie GK, Takeda Pharmaceutical Co., Ltd., and Daiichi Sankyo, Inc. outside the submitted work.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abe, H., Tarasawa, K., Hatta, W. et al. Reply to “Acid suppressants during hospitalization and after discharge in patients after gastroduodenal ESD”. J Gastroenterol 56, 1109–1110 (2021). https://doi.org/10.1007/s00535-021-01824-w

Download citation